Susquehanna Portfolio Strategies, LLC Vericel Corp Transaction History
Susquehanna Portfolio Strategies, LLC
- $2.43 Trillion
- Q2 2024
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Vericel Corp stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 10,900 shares of VCEL stock, worth $436,544. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,900
Previous 12,313
11.48%
Holding current value
$436,544
Previous $641 Million
21.92%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
268Shares Held
48.4MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$323 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$177 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$99.5 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.04MShares$81.8 Million1.42% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.89B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...